Few research compounds have a publication record like GHK-Cu. First isolated from human plasma in the 1970s, this tripeptide-copper complex has accumulated decades of in vitro and preclinical study across skin biology, tissue remodeling, and gene expression research.
A Naturally Declining Molecule
GHK circulates naturally in human plasma, and its measured concentration declines sharply with age — a data point that anchors its role in aging-related research. The peptide binds copper ions with high affinity, and the resulting complex is the biologically studied form.
What In Vitro Studies Examine
The laboratory literature clusters around three areas: stimulation of collagen and glycosaminoglycan synthesis in fibroblast cultures; modulation of both metalloproteinases and their inhibitors — the enzymes that balance tissue breakdown and rebuilding; and broad gene expression effects, with array studies reporting altered expression across thousands of genes.
Position in the Research Catalog
GHK-Cu appears both as a standalone compound and as a component of multi-peptide research blends like GLOW and KLOW. Standalone vials suit mechanism-focused designs; blends suit combination studies. Both are available in our Anti-Aging collection at 99%+ verified purity.
All products discussed are intended strictly for in-vitro research and laboratory use only. They are not for human or veterinary use, consumption, or therapeutic application.
